{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:54:50Z","timestamp":1780055690489,"version":"3.54.0"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781071618998","type":"print"},{"value":"9781071619001","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1900-1_19","type":"book-chapter","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T07:02:59Z","timestamp":1637046179000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets"],"prefix":"10.1007","author":[{"given":"Evgeny A.","family":"Semchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda E.-C.","family":"Jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Seib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.vaccine.2020.02.073","volume":"38","author":"SL Gottlieb","year":"2020","unstructured":"Gottlieb SL, Ndowa F, Hook EW 3rd, Deal C, Bachmann L, Abu-Raddad L et al (2020) Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 38:4362\u20134373. https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.073","journal-title":"Vaccine"},{"key":"19_CR2","volume-title":"Global incidence and prevalence of selected curable sexually transmitted infections - 2008","author":"WHO","year":"2012","unstructured":"WHO (2012) Global incidence and prevalence of selected curable sexually transmitted infections - 2008. World Health Organization, Geneva"},{"key":"19_CR3","doi-asserted-by":"crossref","unstructured":"Braxton J, Davis D, Emerson B, Flagg E, Grey J, La Zetta et al (2018) Sexually transmitted disease surveillance 2017. Centers for Disease Control and Prevention, Atlanta. https:\/\/www.cdc.gov\/std\/stats17\/2017-STD-Surveillance-Report_CDC-clearance-9.10.18.pdf. Accessed 18 Jan 2021","DOI":"10.15620\/cdc.59237"},{"key":"19_CR4","volume-title":"HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018","author":"Kirby Institute","year":"2018","unstructured":"Kirby Institute (2018) HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. The Kirby Institute, UNSW Sydney"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41585-020-00378-5","volume":"17","author":"M Unemo","year":"2020","unstructured":"Unemo M (2020) Optimizations to keep gonorrhoea treatable and reduce antimicrobial resistance selection. Nat Rev Urol 17:609\u2013610. https:\/\/doi.org\/10.1038\/s41585-020-00378-5","journal-title":"Nat Rev Urol"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3109\/1040841X.2015.1105782","volume":"42","author":"JL Edwards","year":"2016","unstructured":"Edwards JL, Jennings MP, Apicella MA, Seib KL (2016) Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development. Crit Rev Microbiol 42:928\u2013941. https:\/\/doi.org\/10.3109\/1040841X.2015.1105782","journal-title":"Crit Rev Microbiol"},{"issue":"71","key":"19_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","volume":"8","author":"PA Rice","year":"2017","unstructured":"Rice PA, Shafer WM, Ram S, Jerse AE (2017) Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development. Annu Rev Microbiol 8(71):665\u2013686. https:\/\/doi.org\/10.1146\/annurev-micro-090816-093530","journal-title":"Annu Rev Microbiol"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin SA (2010) Correlates of protection induced by vaccination. Clin Vaccine Immunol 17:1055\u20131065. https:\/\/doi.org\/10.1128\/CVI.00131-10","journal-title":"Clin Vaccine Immunol"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"e00898","DOI":"10.1128\/IAI.00898-16","volume":"85","author":"EA Semchenko","year":"2017","unstructured":"Semchenko EA, Day CJ, Seib KL (2017) MetQ of Neisseria gonorrhoeae is a surface-expressed antigen that elicits bactericidal and functional blocking antibodies. Infect Immun 85:e00898\u2013e00816. https:\/\/doi.org\/10.1128\/IAI.00898-16","journal-title":"Infect Immun"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/vaccines8020219","volume":"8","author":"EA Semchenko","year":"2020","unstructured":"Semchenko EA, Day CJ, Seib KL (2020) The Neisseria gonorrhoeae vaccine candidate NHBA elicits antibodies that are bactericidal, opsonophagocytic and that reduce gonococcal adherence to epithelial cells. Vaccines (Basel) 8:219. https:\/\/doi.org\/10.3390\/vaccines8020219","journal-title":"Vaccines (Basel)"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fimmu.2019.00137","volume":"10","author":"FE Jen","year":"2019","unstructured":"Jen FE, Semchenko EA, Day CJ, Seib KL, Jennings MP (2019) The Neisseria gonorrhoeae methionine sulfoxide reductase (MsrA\/B) is a surface exposed, immunogenic, vaccine candidate. Front Immunol 10:137. https:\/\/doi.org\/10.3389\/fimmu.2019.00137","journal-title":"Front Immunol"},{"key":"19_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000323","volume":"17","author":"S Gulati","year":"2019","unstructured":"Gulati S, Beurskens FJ, de Kreuk BJ, Roza M, Zheng B, DeOliveira RB et al (2019) Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody. PLoS Biol 17:e3000323. https:\/\/doi.org\/10.1371\/journal.pbio.3000323","journal-title":"PLoS Biol"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0076-6879(94)36013-8","volume":"236","author":"DP McQuillen","year":"1994","unstructured":"McQuillen DP, Gulati S, Rice PA (1994) Complement-mediated bacterial killing assays. Methods Enzymol 236:137\u2013147. https:\/\/doi.org\/10.1016\/0076-6879(94)36013-8","journal-title":"Methods Enzymol"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1080\/21645515.2019.1593082","volume":"15","author":"J Findlow","year":"2019","unstructured":"Findlow J, Balmer P, Borrow R (2019) A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. Hum Vaccin Immunother 15:2491\u20132500. https:\/\/doi.org\/10.1080\/21645515.2019.1593082","journal-title":"Hum Vaccin Immunother"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","volume":"12","author":"R Borrow","year":"2005","unstructured":"Borrow R, Aaberge IS, Santos GF, Eudey TL, Oster P, Glennie A et al (2005) Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine. Clin Diagn Lab Immunol 12:970\u2013976. https:\/\/doi.org\/10.1128\/CDLI.12.8.970-976.2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4939-9202-7_12","volume":"1969","author":"J Lucidarme","year":"2019","unstructured":"Lucidarme J, Louth J, Townsend-Payne K, Borrow R (2019) Meningococcal serogroup A, B, C, W, X, and Y serum bactericidal antibody assays. Methods Mol Biol 1969:169\u2013179. https:\/\/doi.org\/10.1007\/978-1-4939-9202-7_12","journal-title":"Methods Mol Biol"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-62703-724-2_32","volume":"1100","author":"M Dwyer","year":"2014","unstructured":"Dwyer M, Gadjeva M (2014) Opsonophagocytic assay. Methods Mol Biol 1100:373\u2013379. https:\/\/doi.org\/10.1007\/978-1-62703-724-2_32","journal-title":"Methods Mol Biol"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/s0264-410x(03)00230-5","volume":"21","author":"L J\u00f3dar","year":"2003","unstructured":"J\u00f3dar L, Butler J, Carlone G, Dagan R, Goldblatt D, K\u00e4yhty H et al (2003) Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21:3265\u20133272. https:\/\/doi.org\/10.1016\/s0264-410x(03)00230-5","journal-title":"Vaccine"}],"container-title":["Methods in Molecular Biology","Bacterial Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1900-1_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T07:04:00Z","timestamp":1637046240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1900-1_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"ISBN":["9781071618998","9781071619001"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1900-1_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"17 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}